| Name | Sirt1/2-IN-3 |
|---|
| Description | Sirt1/2-IN-3 (compound PS9) is a dual inhibitor of SIRT1/2 with IC50s of 1.4 μM (SIRT1) and 2.0 μM (SIRT2), respsectivley. Sirt1/2-IN-3 completely blocks p53 deacetylation, and increase of p53 and α-tubulin acetylation. Sirt1/2-IN-3 induces apoptosis and shows anti-proliferation activity against human leukemia cell lines[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.4 μM (SIRT1), 2.0 μM (SIRT2), 72.3 μM (SIRT3)[1] |
| References |
| Molecular Formula | C17H14ClNO4S |
|---|---|
| Molecular Weight | 363.82 |